Back to Trades
McMurdo Matthew Charles
DirectorCIK 0001943108
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
McMurdo Matthew Charles, Director, has filed 1 SEC report (2026), all concentrated in Indaptus Therapeutics, Inc. (INDP), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Feb 26 | INDP Indaptus Therapeutics, Inc. | McMurdo Matthew Charles | Director | Other | $0 |
1 filing